Tibet Rhodiola Pharmaceutical Holding Co., Ltd. logo

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211)

Market Open
7 Aug, 06:57
SSE SSE
¥
39. 56
+1.65
+4.3524%
¥
11.3B Market Cap
- P/E Ratio
3.87% Div Yield
6.09M Volume
- Eps
¥ 37.91
Previous Close
Add Transaction
Day Range
37.58 39.69
Year Range
34.8 57.98
Want to track 600211 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600211 trading today higher at ¥39.56, an increase of 4.3524% from yesterday's close, completing a monthly increase of 6.1159% or ¥2.28. Over the past 12 months, 600211 stock lost -7.0052%.
600211 pays dividends to its shareholders, with the most recent payment made on May 22, 2026. The next estimated payment will be in In 3 months on Nov 22, 2026 for a total of ¥0.876.
The last earnings report, released on Apr 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Tibet Rhodiola Pharmaceutical Holding Co., Ltd. has completed 4 stock splits, with the recent split occurring on Apr 30, 2024.
The company's stock is traded on one exchange.

600211 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.47
-0.0954%
Seres Group Co., Ltd.
¥ 55.54
-0.8745%
Great Wall Motor Co., Ltd.
¥ 15.68
-0.0637%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.5
-0.159%
China Tourism Group Duty Free Corporation Limited
¥ 56.02
-0.3912%

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) FAQ

What is the stock price today?

The current price is ¥39.56.

On which exchange is it traded?

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600211.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.87%.

What is its market cap?

As of today, the market cap is 11.3B.

Has Tibet Rhodiola Pharmaceutical Holding Co., Ltd. ever had a stock split?

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. had 4 splits and the recent split was on Apr 30, 2024.

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yuan Dong Guo CEO
SSE Exchange
CNE000000ZW7 ISIN
CN Country
601 Employees
22 May 2026 Last Dividend
7 Sep 2010 Last Split
1 Jul 1999 IPO Date

Overview

Tibet Rhodiola Pharmaceutical Holding Co. is a prominent entity in the pharmaceutical industry, focusing on the research and development, production, and sales of a wide range of pharmaceutical products. Established in 1999 and headquartered in Lhasa, China, the company has made significant strides both in the domestic and international markets. It is renowned for its distinctive product line that encompasses biological products, Tibetan medicine, Chinese medicine, and chemical medicine. Tibet Rhodiola Pharmaceutical Holding Co. leverages the rich medicinal traditions of Tibet along with modern scientific research to create innovative healthcare solutions.

Products and Services

  • Biological Products

    These are pharmaceuticals derived from living organisms and their by-products. Tibet Rhodiola Pharmaceutical Holding Co. utilizes advanced biotechnological processes to develop vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. These products target a broad spectrum of diseases, offering both preventive and therapeutic solutions.

  • Tibetan Medicine

    A traditional system of medicine that has been practiced in Tibet for thousands of years. The company's product lineup in this category includes herbal formulas, mineral preparations, and complex compounds. These products are designed using ancient Tibetan medicinal knowledge, combined with modern pharmaceutical processes to ensure efficacy and safety. Tibetan medicines are known for their unique approaches to diagnosis, treatment, and prevention of illness, focusing on the balance and harmony of the body's elements.

  • Chinese Medicine

    Another ancient form of medicinal practice that Tibet Rhodiola Pharmaceutical Holding Co. specializes in. Their Chinese medicine products include a variety of herbal medicines, acupuncture products, and other traditional therapeutic options. Rooted in centuries-old practices, these products emphasize restoring balance within the body and harnessing natural healing processes. The company's dedication to quality and authenticity makes its Chinese medicine products sought after in both local and international markets.

  • Chemical Medicine

    Comprising synthetic and semi-synthetic pharmaceutical compounds, Tibet Rhodiola Pharmaceutical Holding Co.’s chemical medicine offerings include a wide array of generic and specialized medications. These products are developed in state-of-the-art facilities using cutting-edge chemical synthesis and bioengineering techniques. Aimed at treating a comprehensive range of health conditions, the company’s chemical medicines are known for their potency, purity, and reliability.

Contact Information

Address: Lhasa Economic and Tech Dev Zn, Lhasa, China, 850000
Phone: 86 89 1683 6521